CA1068607A - 2-cyclopropanecarboxamido-5-halothiazoles utilises comme agents anti-inflammatoires - Google Patents

2-cyclopropanecarboxamido-5-halothiazoles utilises comme agents anti-inflammatoires

Info

Publication number
CA1068607A
CA1068607A CA270,844A CA270844A CA1068607A CA 1068607 A CA1068607 A CA 1068607A CA 270844 A CA270844 A CA 270844A CA 1068607 A CA1068607 A CA 1068607A
Authority
CA
Canada
Prior art keywords
halothiazole
edema
compounds
composition
cyclopropanecarboxamido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA270,844A
Other languages
English (en)
Inventor
Don R. Baker
Ferenc M. Pallos
Jack R. Debaun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stauffer Chemical Co
Original Assignee
Stauffer Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/676,770 external-priority patent/US4027031A/en
Application filed by Stauffer Chemical Co filed Critical Stauffer Chemical Co
Application granted granted Critical
Publication of CA1068607A publication Critical patent/CA1068607A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
CA270,844A 1976-04-14 1977-02-01 2-cyclopropanecarboxamido-5-halothiazoles utilises comme agents anti-inflammatoires Expired CA1068607A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/676,770 US4027031A (en) 1975-04-28 1976-04-14 2-Cyclopropanecarboxamido-S-halothiazole as anti-inflammatory agents

Publications (1)

Publication Number Publication Date
CA1068607A true CA1068607A (fr) 1979-12-25

Family

ID=24715924

Family Applications (1)

Application Number Title Priority Date Filing Date
CA270,844A Expired CA1068607A (fr) 1976-04-14 1977-02-01 2-cyclopropanecarboxamido-5-halothiazoles utilises comme agents anti-inflammatoires

Country Status (13)

Country Link
JP (1) JPS52125164A (fr)
AT (1) AT350316B (fr)
AU (1) AU2220177A (fr)
BE (1) BE852075A (fr)
CA (1) CA1068607A (fr)
CH (1) CH626079A5 (fr)
DE (1) DE2708327A1 (fr)
FR (1) FR2348206A1 (fr)
GR (1) GR66154B (fr)
IL (1) IL51483A0 (fr)
NL (1) NL7702432A (fr)
PH (1) PH11483A (fr)
PT (1) PT66258B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57136579A (en) * 1981-01-21 1982-08-23 Mitsui Toatsu Chem Inc Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
EP0068033B1 (fr) * 1981-01-08 1985-07-10 Mitsui Toatsu Kagaku Kabushiki Kaisha Derives de n-(4-phenyl-2-thiazolyl)carbamate, procede de preparation et composition medicinale les contenant
JPS57116067A (en) * 1981-01-12 1982-07-19 Sankyo Kagaku Kk Novel 8-quinolinesulfonyl derivative, its synthesis and use
WO1982002383A1 (fr) * 1981-01-13 1982-07-22 Sakano Isao Nouveaux composes de thiazol, procede de preparation, et composition medicinale en contenant
WO1982002386A1 (fr) * 1981-01-13 1982-07-22 Sakano Isao Derives d'aminothiazoles, procede de preparation et composition medicinale les contenant
GB9823871D0 (en) * 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents

Also Published As

Publication number Publication date
PT66258B (en) 1978-08-07
NL7702432A (nl) 1977-10-18
ATA98477A (de) 1978-10-15
DE2708327A1 (de) 1977-11-03
GR66154B (fr) 1981-01-19
BE852075A (nl) 1977-09-05
FR2348206B1 (fr) 1980-03-07
AU2220177A (en) 1978-08-17
PH11483A (en) 1978-02-01
CH626079A5 (en) 1981-10-30
PT66258A (en) 1977-04-01
AT350316B (de) 1979-05-25
IL51483A0 (en) 1977-04-29
FR2348206A1 (fr) 1977-11-10
JPS52125164A (en) 1977-10-20

Similar Documents

Publication Publication Date Title
US4503065A (en) Antiinflammatory 4,5-diaryl 1-2-halo imidazoles
KR100438633B1 (ko) Ｎ-(3-벤조푸라닐)우레아 유도체
US4383994A (en) Homocysteine thiolactone salts and use thereof as anti-neoplastic agents
EP0003056A1 (fr) Acides oméga-aminoalcanoyl-oméga-aminoalcanecarboxyliques N-substitués, leur utilisation et procédé pour leur préparation ainsi que médicaments contenant ces composés
CA1068607A (fr) 2-cyclopropanecarboxamido-5-halothiazoles utilises comme agents anti-inflammatoires
US4027031A (en) 2-Cyclopropanecarboxamido-S-halothiazole as anti-inflammatory agents
US5280045A (en) 4(3,5-bis(1,1-dimethylethyl-4-hydroxyphenyl)-4-oxobutanamide compound useful as an anti-inflammatory agent
US3959368A (en) N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent
US3947475A (en) 5-Furoyl-2,2,4-trimethyl-1,4-dihydro-1H-1,5-benzodiazepine as an anti-inflammatory agent
US4012527A (en) N,N-Dimethyl-N'-phenylthiocarbamyl formamidine hydrochloride and its use as an anti-inflammatory agent
US3998970A (en) N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent
US4134900A (en) 5,6-Dihydro-4-oxo-4H-thieno[2,3-b]thiopyran-5-carboxamides, and process for the preparation thereof
US4590205A (en) Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes
US3978227A (en) 5-furoyl-2,2,4-trimethyl-1,4-dihydro-1h-1,5-benzodiazepine as an anti-inflammatory agent
US3978202A (en) ο-Chlorobenzamidoxime as an anti-inflammatory agent
JP2005527518A (ja) 新規なカルコン（ｃｈａｌｃｏｎｅ）誘導体とその使用
US3968224A (en) 3-(4'-Chlorophenyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazole, its use as an anti-inflammatory agent
JPH01228975A (ja) ベンゾチアジン―１，１―ジオキシド誘導体及びそれを含有する医薬組成物
US5196567A (en) Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
AT390437B (de) Tromethamin-salz von 1-methyl-beta-oxo-alpha(phenylcarbamoyl)-2-pyrrol-propionitril
CA1133913A (fr) N-(1-methyl-2-pyrrolidinyl-methyl)-2,3-dimethoxy-5- methylsulfamoyl benzamide et ses derives; leurs methodes de preparation, et leur utilisation dans le traitement de troubles de l'appareil urinaire inferieur
EP0079639B1 (fr) Médicament anti-inflammatoire
EP0008367A1 (fr) N-Arylsulfonyl-pyrroles, leur préparation et médicaments les contenant
EP0045473B1 (fr) Composition pharmaceutique contenant comme principe actif un dérivé du benzofuranne carboxamide
EP0381141B1 (fr) Dérivés d'acides aryl- ou hétéroaryl-1-alkyl-pyrrole-2-carboxyliques utiles dans le traitement de maladies en relation avec l'interleukine-1